{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-002738","form_type":"8-K","ticker":"ACON","cik":"0001635077","company_name":"Aclarion, Inc.","filed_at":"2025-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.142176+00:00","generated_at":"2026-05-23T08:11:50.448030+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Aclarion updates investor deck: $14.6M cash, UK payer approvals, CLARITY trial on track for interim Q2 2026","bullets":["Cash on hand ~$14.6M as of Apr 9 2025 10-K; runway into Q3 2026; zero debt, no preferred shares, no near-term warrant overhang.","Secured UK payer approvals: three of top four private medical insurers now cover Nociscan, representing 5.2M people.","Pivotal CLARITY trial fully funded ($4.6M total); first patient estimated Q2 2025; interim results expected Q2 2026.","Expanded U.S. physician referral and commercial support; CPT Category III codes 0609T/0611T in place; Nociscan list price $1,450 vs discogram $2,000-$5,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-002738","json":"https://secwatch.observer/filing/0001683168-25-002738.json","markdown":"https://secwatch.observer/filing/0001683168-25-002738.md","text":"https://secwatch.observer/filing/0001683168-25-002738.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635077/000168316825002738/0001683168-25-002738-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635077/000168316825002738/aclarion_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T08:11:50.448030+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}